DXCM241101C48500
- 0.00
- 0.000.00%
DexCom Newsroom
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
DexCom (DXCM) Fell Due to an Uncharacteristic Earnings Miss
Friday Market Climbs on Amazon Earnings, Labor Numbers at Four-Year Low | Live Stock
Thursday, Halloween Market Falls in Scary Reaction to Earnings | Wall Street Today
Halloween Market Falls, Scared of Meta and Microsoft CapEx | Live Stock
Market Flips and Falls as Meta and MSTR Fall After Earnings | Wall Street Today
Is DexCom, Inc. (NASDAQ:DXCM) The Worst Performing S&P 500 Stock In 2024?
Market Climbs, SMCI Auditors Allege Mischief on Mischief Night | Live Stock
Stocks With Cheap Implied Volatility – JPM
Multiple Headwinds Dragged DexCom (DXCM) in Q3
Nasdaq Hits Record High While Wed Earnings Are Mixed | Wall Street Today
Tuesday Market Falls on Tough Earnings, With AMD and Alphabet Reporting Tonight | Live Stock
Glucoguard, a Division of ADHC, Completes AI Based Mobile Application and Design Outline (MADO) for Dexcom API Integration
Insulcloud Receives FDA Clearance to Expand Proprietary Diabetes Management Solution Insulclock CAP Into U.S. Market
Slow Day to Start Busy Week | Wall Street Today
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
Stocks on Sale: Colgate-Palmolive, DexCom, and Realty Income
J.P. Morgan Downgrades DexCom(DXCM.US) to Hold Rating, Cuts Target Price to $85
A Quick Look at Today's Ratings for DexCom(DXCM.US), With a Forecast Between $85 to $115